- Home
- FC vs HUMA Comparison
FC vs HUMA Comparison
Compare FC & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FC
- HUMA
- Stock Information
- Founded
- FC 1983
- HUMA 2004
- Country
- FC United States
- HUMA United States
- Employees
- FC N/A
- HUMA N/A
- Industry
- FC Other Consumer Services
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- FC Consumer Discretionary
- HUMA Health Care
- Exchange
- FC Nasdaq
- HUMA Nasdaq
- Market Cap
- FC 239.1M
- HUMA 250.2M
- IPO Year
- FC 1992
- HUMA N/A
- Fundamental
- Price
- FC $19.29
- HUMA $1.53
- Analyst Decision
- FC Strong Buy
- HUMA Strong Buy
- Analyst Count
- FC 2
- HUMA 8
- Target Price
- FC $27.00
- HUMA $10.88
- AVG Volume (30 Days)
- FC 134.7K
- HUMA 2.9M
- Earning Date
- FC 11-05-2025
- HUMA 11-07-2025
- Dividend Yield
- FC N/A
- HUMA N/A
- EPS Growth
- FC N/A
- HUMA N/A
- EPS
- FC 0.81
- HUMA N/A
- Revenue
- FC $279,943,000.00
- HUMA $818,000.00
- Revenue This Year
- FC N/A
- HUMA N/A
- Revenue Next Year
- FC $1.23
- HUMA $1,619.38
- P/E Ratio
- FC $23.75
- HUMA N/A
- Revenue Growth
- FC N/A
- HUMA N/A
- 52 Week Low
- FC $18.13
- HUMA $1.15
- 52 Week High
- FC $44.16
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- FC 49.03
- HUMA 42.17
- Support Level
- FC $18.79
- HUMA $1.45
- Resistance Level
- FC $19.50
- HUMA $1.53
- Average True Range (ATR)
- FC 0.68
- HUMA 0.09
- MACD
- FC 0.05
- HUMA 0.04
- Stochastic Oscillator
- FC 58.88
- HUMA 51.72
About FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.